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Abstract
Foxp3+ T-regulatory cells (Tregs) normally serve to attenuate immune responses and are key to maintenance of immune
homeostasis. Over the past decade, Treg cells have become a major focus of research for many groups, and various functional
subsets havebeen characterized. Recently, the Ikaros family member, Helios,was reportedas a marker to discriminate naturally
occurring, thymic-derived Tregs from those peripherally induced from naı ¨ve CD4+ T cells. We investigated Helios expression in
murine and human T cells under resting or activating conditions, using well-characterized molecules of naı ¨ve/effector/memory
phenotypes, as well as a set of Treg-associated markers. We found that Helios-negative T cells are enriched for naı ¨ve T cell
phenotypes and vice versa. Moreover, Helios can be induced during T cell activation and proliferation, but regresses in the
same cells under resting conditions. We demonstrated comparable findings using human and murine CD4+Foxp3+ Tregs, as
well as in CD4+ and CD8+ T cells. Since Helios expression is associated with T cell activation and cellular division, regardless of
the cell subset involved, it does not appear suitable as a marker to distinguish natural and induced Treg cells.
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Introduction
T-regulatory cells (Tregs) constitute a functionally important
subset of lymphocytes capable of fine tuning the immune response
against pathogens and environmental stimuli [1]. Tregs are pivotal to
maintainingself-toleranceandpreventingautoimmunity,butarealso
involved in limiting physiologic immune and antitumor activity [2].
The ability to control Treg function could have major therapeutic
potential for conditions ranging from autoimmune diseases and
transplantation to malignancies, such that many investigators have
begun to characterize Treg phenotypes and aspects of their biology.
The transcription factor, Foxp3, is well recognized as central to Treg
function [3,4]. However, even Foxp3 is not absolutely Treg-specific,
given its expression by activated T cells [5], and at least one report,
some non-lymphoid cells [6], thereby limiting its utility as a universal
Treg marker. Defining functional subsets of Treg is even more
complicated, though Tregs can be divided into the two broad
categories of natural occurring thymus-derived Tregs (nTreg), and
peripherally induced Tregs (iTreg) that can develop from naı ¨ve T
cells under a variety of conditions [7]. Both subsets share similar
molecular signatures, including expression of Foxp3, high expression
of CD25 [8] and CTLA-4 [9], and low expression of CD127 [10],
and share multiple suppressive mechanisms [11]. These close
similarities make ready discrimination of nTregs and iTregs nearly
impossible. However, being able to determine the origin of a given
Treg may be of importance in basic studies of Treg biology, or when
monitoring the success of therapeutic interventions aimed at altering
Treg production or function.
Some additional molecules have been proposed to discriminate
between nTreg and iTreg. For example, CD31 (PECAM-1) is
reportedly expressed by recent thymic emigrant CD4+ T cells but
not by peripherally expanded naı ¨ve T cells [12,13]. CD31 is cleaved
and shed from the surface of human T cells upon activation via the
T cell receptor (TCR) [14], and declines with aging, along with
thymic involution [15]. Recently, several microarray studies
indicated an up-regulation of the Ikaros family transcription factor,
Helios, in Tregs [16,17,18]. Ikaros DNA-binding proteins are
characterized by two highly conserved zinc finger domains that
mediateDNA(N-terminaldomain)andproteinbinding(C-terminal
domain) [19]. The Ikaros family is comprised of 5 members;
Pegasus and Eos are present in all tissues, whereas Ikaros, Aeolus,
and Helios are selectively expressed in lymphocytes [20]. Recently,
Thornton et al. reported that nTregs but not iTregs express Helios
[21], thereby generating much interest in Helios and Treg subsets
[22]. Considering the importance of identifying nTreg from iTreg,
we decided to investigate the role of Helios in mice and human T
cells using well-characterized molecules of naı ¨ve/effector/memory
phenotypes, as well as Treg-associated markers.
Results
Helios co-expression with T cell and Treg-associated
markers
We first assessed Helios expression by flow cytometric analysis
of human and murine peripheral blood mononuclear cells
(PBMC), plus cells from murine lymph nodes and spleens.
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Foxp3+ Treg showed the highest Helios expression in both species
(Table 1). There were no gender-based differences in Helios
expression when tested using age-matched samples (data not
shown). In mice, Helios+ T cells from lymph nodes and spleen
were more likely to co-express Foxp3 and CD25 than PBMC
(Figure 1A). In human CD4+ cells, the highest levels of Helios
expression were associated with Foxp3, CD25, CD39, CTLA-4
(CD152) and low levels of CD127, while intermediately positive
Helios+ cells included non-Treg cells (Figure 1B). Importantly,
CD4+ Helios+ and CD4+ Helios- cells expressed CD31, a marker
of recent thymic emigrant cells, almost equally (Figure 1B).
Together, these data suggest that Helios might not be a specific
marker of nTreg cells.
Helios expression and T-cell maturation
Flow cytometric analysis showed murine CD4+ Helios- T cells
were mostly naı ¨ve CD62L+ CD44- cells, whereas CD4+ Helios+
T cells were enriched for memory (CD62L+ CD44+) or effector
(CD62L- CD44+) phenotypes (Figure 2A). These data suggested
that Helios might be induced by T cell activation. Indeed, Helios+
cells largely lacked expression of CD45RB, a CD45 isoform of
naı ¨ve cells (Figure 2B). Since iTreg undergo T cell receptor
(TCR) stimulation during conversion, they are less naı ¨ve in
phenotype than nTregs. Assessment of markers of cell maturation
using murine CD4+Foxp3+ Tregs gated into Helios+ or Helios-
subsets showed that murine CD4+ Foxp3+ Helios- Tregs had
twice as many naı ¨ve CD45RB+ cells, and only half as many
CD44+ effectors/memory cells, as Helios+ Tregs (Figure 2C).
Table 1. Helios expression in mononuclear cells.
Cell population % Helios+ murine cells (mean ± SEM) % Helios + human cells (mean ± SEM)
Blood LN Spleen Blood
CD4+cells 13.460.8 12.361.2 11.260.6 12.661.2
CD4+ Foxp3+ cells 79.760.7 74.863.5 76.763 63.461.2
CD4+ Foxp3- cells 6.6622 . 8 60.6 3.861.3 3.560.7
CD8+ cells 6.962.9 4.660.5 7.460.9 21.863.5
CD4- CD8- cells 3.860.3 4.461.2 3.260.4 16.162.8
doi:10.1371/journal.pone.0024226.t001
Figure 1. Helios expression was not restricted to CD4 cells, but among CD4+ cells correlated with Treg-associated markers. (A)
Expression of Helios in murine lymphocytes (left column) and CD25+ Foxp3+ co-expression in CD4+ Helios+ gated subsets (right column) of blood
(top), lymph nodes (middle) and spleen (bottom). (B) Expression of Helios in human lymphocytes (top) and co-expression of Helios with Treg-
associated markers in cells gated for CD4 expression. Right column, bottom row shows absence of correlation between Helios and CD31, a marker of
recent thymic emigrants cells. Data are representative of 5 experiments.
doi:10.1371/journal.pone.0024226.g001
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(CD4+Foxp3+) or conventional CD4+ Foxp3- T cells and CD8+
T cells being enriched for mature CD45RO+ CD45RA- cells,
whereas Helios- populations exhibited the more naı ¨ve CD45RO-
CD45RA+ phenotype (Figure 2D). These data support the
concept that Helios may be a marker of T cell activation.
Helios expression upon T cell activation
We tested whether Helios expression is a marker of T cell
activation by studying Helios expression in Tregs and T-effector
cells (Teffs) during standard in vitro Treg suppression assays. In
these assays, Teffs are stimulated using CD3 mAb and antigen-
presenting cells (APC), in the presence of varying proportions of
Tregs, for 3 days (murine cells) or 4 days (human cells). To
monitor their divisions during each assay, Teff cells were labeled
with CFSE (carboxyfluorescein succinimidyl ester). Numerous
murine CFSE+ CD4+ Teffs acquired a Helios+ phenotype, and by
day 3, 25–30% of mouse Teffs were Helios+ (Figure 3A & 3C);
this was an ,6-fold increase in Helios expression compared to
freshly isolated CD4+CD25- cells (Table 1). As bead-isolated
CD4+ CD25- Teffs could be contaminated by small numbers of
Treg cells that could divide and cause an increase in Helios+ T
cells, we assessed expression of Foxp3 and Helios by Teffs
immediately post-isolation and after suppression assays. Initially,
bead-isolated Teffs had about 3% of Foxp3+ and 6% of Helios+
cells (data not shown). After the suppression assay, Foxp3+
expression in CFSE+ murine cells, caused by contaminant Tregs,
did not change (Figure 3A, upper row), whereas Helios
expression increased markedly (Figure 3A, lower row). This
finding suggested that murine CD4+ Teffs could acquire
expression of Helios, but not Foxp3, under the conditions of
TCR stimulation in a Treg suppression assay.
Next, we assessed Foxp3 and Helios expression as a function of
Treg proliferation. To study division of Tregs and Teffs in parallel,
we labeled CD4+ CD25- Teffs with CFSE, and CD4+ CD25+
Tregs with ‘‘CellTrace’’, a label with similar dye dilution
characteristics to those of CFSE, albeit with a different emission
frequency on flow cytometry. This enabled us to separate Treg
proliferation signals from dividing effector T cells. We found that
Tregs had a multiple division peaks, with more at the lowest Treg
to Teff cell ratios, ranging from 62% of dividing cells in 1:1
(Figure 3B, upper row, left) to 76% in 1:4 Treg to Teff ratios
(Figure 3B, upper row, right). By comparing dividing and
non-dividing Treg, we found that only proliferating Tregs were
able to keep Foxp3 and co-express Helios, while non-dividing
Tregs lost both molecules almost completely (Figure 3B, lower
row). To assess whether Tregs can induce Helios expression in
Teffs as a part of a putative suppressive mechanism, we compared
Helios expression in CD4+ CFSE+ Teffs at different Treg to Teff
cell ratios. We found that Helios expression by Teff cells did not
depend upon the proportions of Tregs added (Figure 3C).
Although we showed that highly activated Teffs can become
Helios+ under the conditions of a Treg suppression assay, it
remained unclear whether this Helios+ phenotype reflected a type
of negative-feedback loop preventing hyperactivation, or was
primarily related to cell activation, akin to CD25 expression.
Therefore, we defined Helios+ and Helios- Teff subsets and
analyzed separately their cellular division rates. As seen in
Figure 3D, Helios+ Teffs exhibited much higher division
throughout all Treg to Teff ratios. Therefore, Helios+ Teffs are
a subset of highly activated and dividing effector T cells that are
relatively resistant to Treg suppression. Likewise, human CD4+
CD25-, and even CD8+ T cells acquired Helios during a Treg
suppression assay (Figure 3E & 3F, and Figure 4A & B). As with
Figure 2. Helios- cells appeared more naı ¨ve than Helios+ T cells. (A) Expression of CD62L and CD44 in Helios+ (left column) and Helios- (right
column) gated CD4+ cells in murine blood (top) and lymph nodes (second row). (B) Negative correlation between Helios and CD45RB expression in
murine lymph nodes and spleen. (C) Expression of CD44 and CD45RB in Helios+ and Helios- gated Tregs in murine lymph nodes. (D) Maturation
phenotype in human Tregs (top row), CD4+ Foxp3- Teffs (middle) and CD8+ T cells (bottom row) gated on Helios+ (left column) and Helios- (right
column) subsets. Data are representative of 4 experiments.
doi:10.1371/journal.pone.0024226.g002
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were more resistant to suppression and had higher rates of cellular
division (Figure 3E & 3F).
To investigate the relationship of Helios expression with cell
division and resistance of Teff cells to Treg suppression, we studied
co-expression of Helios with Ki-67, a marker for cellular
proliferation, as well as CD120b (TNFR2, the type 2 TNF
receptor), a proposed marker for Teff cells resistant to suppression,
under the conditions of a human Treg suppression assay
(Figure 4A). Most dividing Ki-67+ Tregs were Helios+
(Figure 4B, left column). The majority of Helios positive
CD4+ and CD8+ T cells were negative for Foxp3, despite some
acquired Foxp3 expression in CD4+ (14%) and CD8+ (2.4%) cells
(Figure 4B, upper row). Most Helios+ Teffs were highly
proliferative (Figure 4B, middle row). Finally, CD120b
expression correlated with Helios expression in Tregs, CD4+
and in CD8+ Teffs (Figure 4B, lower row), confirming the
activated phenotype of Helios+ Tregs and resistance to suppres-
sion of Helios+ T effectors. These data further supported the
hypothesis that Helios may be a marker of activated and dividing
T cells.
To further substantiate this concept, we investigated the
relationship between Helios and Foxp3 expression and matura-
tion/activation phenotype in T cells under the condition of a Treg
suppression assay. We divided human CD4+ Teffs (Figure 5A),
CD8+ (not shown) and Tregs (Figure 5B) after suppression assay
into four subsets: Helios+ Foxp3+, Helios- Foxp3+, Helios+
Foxp3- and Helios- Foxp3- cells, and analyzed CD45RA,
CD45RO and CD62L expression. We observed that human T
cells gradually lost CD45RA expression during cell divisions,
developed CD45RO expression and mostly kept CD62L expres-
sion, forming three subsets: fully maturated CD62L+ (or low)
CD45RO+ CD45RA- cells, naı ¨ve CD62L+ CD45RO-CD45RA+
cells and activated CD62L+ CD45RA+ CD45RO+ cells which
have already acquired CD45RO marker, but still kept CD45RA
and CD62L expression. Hence, two Foxp3+ subsets, independent
of Helios expression, were enriched for mature effector and
memory cells, while Helios+ Foxp3- cells were composed of highly
activated CD45RA+ CD45RO+ cells, and double negative Foxp3-
Helios- subsets were enriched for naı ¨ve cells (Figure 5). The same
patterns were observed for CD8+ effector T cells (not shown).
These data further supported our hypothesis of Helios upregula-
tion upon T cell activation.
IL-2 enhances Helios expression in stimulated T cells
without acquisition of a Treg phenotype
Recently, a new Treg-associated surface marker called GARP
was suggested to discriminate ‘‘true’’ suppressive Tregs from
activated CD25+ CD127
low Foxp3+ CTLA-4+ expressing Teff
cells [23]. To induce GARP expression, cells need to be activated
Figure 3. Upregulation of Helios expression by Teff cells in suppression assays. (A) Analysis of CD4+ gated murine Tregs and Teffs after 3
days of suppression assay showed that while Tregs gradually lose Foxp3 (top) and Helios (bottom) expression, a substantial proportion of Teff cells
upregulate Helios (bottom), but not Foxp3 (top) expression; CFSE-negative gates show Tregs. (B) Treg division during suppression assays correlated
with Helios and Foxp3 co-expression, while non-dividing Tregs lost both markers. Upper row: gating of dividing and non-dividing Tregs, with
numbers showing % of Treg divisions at 1/1 (left), K (middle) and J (right) ratios; arrows point to Helios and Foxp3 co-expression in corresponding
divided and non-divided Tregs subsets through the same 1/1 to J Treg/Teff ratios. (C) Tregs do not induce Helios expression in Teffs since CFSE+
CD4+ Teffs have similar Helios expression despite differing numbers of Tregs (1/1, K and J ratios shown). (D) Analysis of Teffs gated into Helios+
and Helios- subsets showed Helios+ Teffs have a higher division rate and greater resistance to Treg suppression than Helios- mouse Teffs. Human
Helios+ CD4+ (E) and Helios+ CD8 (F) Teffs showed higher divisions than Helios- cells regardless of Treg presence or absence, and Helios+ responder
cells were more resistant to suppression than Helios- responders. Data are representative of 3 experiments.
doi:10.1371/journal.pone.0024226.g003
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24 hours. We studied Helios and GARP co-expression in mice and
human lymphocytes, and assessed whether Helios expression
could be enhanced by the addition of IL-2. We found that IL-2 led
to a moderate increase in Helios expression from 4 to 11%, and
from 12 to 21%, in murine and human CD4+ T cells, respectively
(Figure 6A, upper row and 6B, middle row). Of note,
Helios+ cells were also Ki-67+. At the same time, IL-2 did not
increase Foxp3 expression, and the IL-2 treated Helios+ subset
was enriched with Foxp3- cells (Figure 6 A & 6B, middle
rows). The addition of IL-2 led to a minor increase in GARP
expression, perhaps due to short time and sufficient level of
internal IL-2 from non-Treg cells. However, GARP did not
correlate with Helios expression in CD4+ or in CD4+Foxp3+ cells
(Figure 6A, B, lower rows), with or without addition of IL-2.
Restricting the incubation period to 24 hours allowed detection of
increases in Helios expression that were independent of cell
division, and again underlined the association of Helios expression
with cellular activation.
Helios expression is not associated with Treg lineage
commitment
Given that Helios and Foxp3werebothelevated inthefraction of
dividing Tregs in the suppression assay (Figure 3B & 4B), we
considered whether Helios might be important for stabilizing the
Foxp3+ Treg phenotype. We stimulated Teff cells to become
Foxp3+ iTreg by CD3e/CD28 co-stimulation, in the presence of
3 ng/mL TGF-beta, for four days; these sub-optimal conditions
ensured that some Foxp3- cells remained available for comparisons.
Approximately 30% of CD4+ CD25- Foxp3- T-cells became
Foxp3+ and 22% upregulated Helios, in both Foxp3+ and Foxp3-
subsets, with a higher percent of Helios+ cells in iTregs. Next, we
removed CD3e/CD28, as well as TGF-beta stimulation, and
cultured the cells in IL-2 (25 U/ml) for an additional 4 days. We
found that the removal of stimulation resulted in a decline of Helios
expression (Figure 7A). The same finding was seen when freshly
isolated CD4+CD25+ nTreg were incubated in IL-2 (25 U/ml, 4
days) without stimulation. The fraction of Helios+ cells declined
sharply, and the Foxp3+ decrease occurred mostly among the
Helios+ cell subset since the proportion of Helios-Foxp3+nTregs
changed slightly, from 23 to 20% (Figure 7B). Of note, the
induction of Helios was seen in CD8+ as well as CD4+ T cells. We
induced Foxp3+ in CD8+ T-cells by stimulating them under the
same conditions as in Figure 7A, and found that both Helios and
Ki-67 were upregulated together in stimulated CD8+ cells
(Figure 7C), similar to what we observed with human CD8+ cells
in the Treg suppression assay.
Helios and Ki-67 are co-expressed by murine T-cells in
vivo
Given our observations that Helios was associated with cellular
activation and division in vitro, we tested cells from normal murine
thymi, spleens and lymph nodes for co-expression of Helios and a
marker of cellular proliferation, Ki-67 (Figure 8). We found that
compared to cells from the spleen and lymph nodes, the thymus
was highly positive for CD4+ T cells expressing both Helios and
Ki-67. Next, we investigated the Ki-67-positive fractions of
CD4+CD8-Foxp3/Helios subsets. We found that Helios+ cells
were enriched for Ki-67 expression throughout each subset of
CD4+ (Figure 8A) and CD8+ T cells (not shown).
Figure 4. Helios expression in suppression assay is associated with cell activation and division. (A) After suppression assays, human
Tregs and responders PBMC cells (1/2 Tregs/responders ratio) were stained for CD4, Helios, Ki-67, Foxp3 and CD120b; gating of live lymphocytes and
co- expression of listed markers with CFSE divisions peaks shown, cells in CFSE-negative gate are Tregs. (B) Helios+ Tregs but not CD4+ and CD8+
responders showed co-expression of Helios and Foxp3 (top row). Helios+ cells showed more dividing (middle) and activated (bottom) phenotypes
throughout all T cells subsets, including Tregs (left), CD4+ (middle) and CD8+ (right) cells. Data are representative of 2 experiments.
doi:10.1371/journal.pone.0024226.g004
Helios Is a Marker of T Cell Activation
PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e24226Foxp3+ Helios- cells in the thymus do not originate from
peripheral iTreg
To study the possible origin of Foxp3+ Helios- cells in the
thymus, we tested expression of CD4 and CD8 within this
population. Of note, 62% of Foxp3+ Helios- cells and 24% of
Foxp3
high Helios- cells exhibited the double-positive CD4+CD8+
stage of thymic development, which argued against the idea that
Foxp3+ Helios- cells are recirculating iTregs cells that were
induced in the periphery (Figure 9A). To study Helios expression
in thymocytes in resting conditions, we divided freshly isolated
cells into 2 portions, and cultured them with IL-26CD3/CD28
stimulation for 3 days. Despite the presence the thymic APC cells
in these cultures, unstimulated cells lost almost half their Ki-67
expression (59.5% vs. 97% in stimulated cells, and vs. 90% in fresh
thymocytes) and most Helios expression (10% vs. 74% in
stimulated cells, and vs. 27% of Helios+ cells in fresh thymocytes)
(Figure 9B, top and middle rows). However, in unstimulated
conditions, 68% of Foxp3+ cells were still Ki-67+ (Figure 9B,
top, left), suggesting that Tregs were not as dependent upon
TCR stimulation to divide as conventional T cells. In spite of this,
CD4+ SP Foxp3+ Tregs markedly lost Helios expression: 57%
Helios+ cells in non-stimulated thymic Tregs vs. 91% in stimulated
Tregs (Figure 9B, bottom) and vs. 90% in ex-vivo thymic Tregs
(data not shown).
In these studies, we can exclude the possibility of overgrowth of
thymic Helios+ nTregs (which stopped division) by peripheral
Helios- iTregs (which continued dividing) for multiple reasons.
First, the proportions of Helios+ cells in gated dividing Ki-67+ and
Figure 5. Helios is associated with an activated non-mature phenotype in suppression assays. After suppression assays (1/2 Treg/
responder ratio), human CD4+ Teffs (A) and Tregs (B) were divided into 4 subsets according to Helios and Foxp3 co-expression. Helios+Foxp3- cells
had the least mature and the most activated phenotypes in human CD4+ Teffs (A) and Tregs (B) in suppression assays, while Foxp3 expressing cells
were enriched for mature CD45RO+ CD45RA- subsets. Data are representative of 2 experiments.
doi:10.1371/journal.pone.0024226.g005
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was the same, 57%, and, respectively, the proportions of Ki-67+
dividing cells in Helios+ and Helios- subsets of CD4+ SP Foxp3+
Tregs in resting conditions were the same, 62% and 63%. Second,
in resting conditions 21% of all Ki-67+ dividing Foxp3+ Helios-
thymocytes were immature DP CD4+CD8+ cells, the type of cells,
which don’t originate in peripheral tissues. Third, the proportion
of cells with compromised membranes (Dead+ cells within the
lymphocyte gate as determined using the LIVE/DEAD Fixable
Dead Cell Stain Kit) in non-stimulated conditions was the same as
in stimulated cells; these consisted of a negligible number of
Foxp3+ cells (0.2%), and half of them (47%) were Helios-. Lastly,
the proportion of Foxp3+ cells was similar in resting and in
activated conditions of thymic cells (Figure 9 B, top). Hence, the
viability of Helios+ and Helios- cells in resting conditions was the
same, and loss of Helios+ Tregs could not be explained by
preferential survival of a Helios- subset. As a result, thymic Tregs
cells are Helios+ due to their activation/division state and not their
site of origin, and this Helios+ phenotype is changeable even for
thymocytes.
Helios expression of Helios by in vitro expanded Tregs
and in clinical transplant recipients
Our lab undertakes immune monitoring of adult and pediatric
liver transplant recipients receiving standard triple therapy of
calcineurin inhibitor, corticosteroids and azathioprine. In adults,
we collect blood pre-transplant, plus in the first week post-
transplant and at 3 months, whereas in children, blood is collected
only from patients with stable graft function and no episodes of
rejection during the prior 6 months. In both projects, Tregs are
isolated using magnetic beads and tested in Treg suppression
assays. Within these samples, no correlation between Treg
expression of Helios and donor age was observed (Table 2). We
likewise studied Helios expression in control healthy donors, aged
25–40 years. Interestingly, the highest Helios expression was seen
with expanded Tregs from a healthy male donor (Table 2). While
observations involving expanded Tregs might be explained in
different ways, including variation in Foxp3 expression or the
period of stimulation/activation of these cells, other samples had
comparable Foxp3 expression (60%–70%) and should have
correlated with age if Helios expression reflected a thymic origin
of Tregs.
Foxp3 demethylation within the TSDR (Treg-specific demeth-
ylated region) of human Tregs distinguishes nTreg from iTregs
produced in vitro or from activated, transiently Foxp3+ Teff cells
[24], and might provide additional light on the relationship of
Helios expression and FOXP3. We therefore examined Helios
expression, Foxp3 demethylation and Treg function using cells
isolated from serial blood samples of two adult liver transplant
recipients. Compared to levels in the first week post-transplant,
Helios expression by patient Tregs was decreased at 3 months
post-transplant (Table 3). While this may be consistent with
increased iTregs populations, other data in Table 3 argue against
this viewpoint. First, liver transplantation caused an increase,
rather than a decrease, in Treg expression of CD31 (Figure 10A),
a marker of recent thymic emigrants, followed by increase of naı ¨ve
CD45RA+ subset (1
st patient) or a decrease of CD45RO+ mature
subset of Tregs (2
nd patient). Second, we noted decreased Foxp3
demethylation in one patient, while the other exhibited increased
Foxp3 demethylation. Third, Treg suppressive function, shown in
Table 3 as area-under curve (AUC) data [25], improved in the
female patient with autoimmune liver pathology, along with
increased Foxp3 demethylation, and declined in the male patient
with alcoholic liver disease, along with decreased Foxp3
demethylation. Such data were consistent with the correlation
between Foxp3 demethylation and Treg function, whereas no
comparable link was found between Helios expression and thymic
Figure 6. IL-2 increased Helios expression in Ki-67+ Foxp3- GARP- cells. Murine MNC from lymph nodes and spleen (A) and human PBMC (B)
were stimulated with CD3/CD286IL-2 for 24 hrs and stained for CD4, Foxp3, Helios, Ki-67 and GARP. IL-2 addition led to a slight increase in
expression of Helios by Ki-67+ (A, top) CD4+ and CD4- (B, top) and Foxp3- cells (A, B, middle rows). Helios expression was not associated with GARP
expression in CD4+ gated (A, bottom) or Foxp3+ gated (B, bottom) cells.
doi:10.1371/journal.pone.0024226.g006
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Lastly, we tested assess whether Helios expression in Tregs was
associated with changes in normal healthy donor Treg suppressive
function induced by pharmacologic treatment with a histone/
protein deacetylase inhibitor (HDACi) or a DNA methyltransfer-
ase inhibitor (DNMTi) [25]. We found that treatment with an
HDACi (SAHA) or a DNMTi (Decitabine) increased human Treg
suppressive function in vitro, but Helios expression in Tregs
remained unchanged (Figure 10B).
Discussion
Helios is a highly conserved transcription factor that has 97%
sequence homology between humans and mice [26]. Previous
studies showed that constitutive expression of Helios in T cells led
to inhibition of thymic T cell development [27], while a mutation
negating DNA binding ability led to T cell leukemia in both mice
[27] and humans [28]. However, full knockout of Helios in mice
did not significantly affect T cell development, including that of
Foxp3+ Tregs [29], suggesting the compensatory potential of
residual Ikaros family members. Recently, Thornton et al [21]
reported that Helios expression in human and murine Tregs could
discriminate thymic-derived nTregs from iTregs, as nTregs co-
expressed Helios but iTregs developing in vitro or in vivo did not. In
a subsequent letter, Verhagen and Wraith, in studies of iTreg
induction from Teff cells of Rag-deficient Tg4 transgenic mice
Teffs to induce Tregs, suggested that the method of in vitro
activation (i.e. the presence or absence of APC), rather than the
thymic vs. peripheral origin of Foxp3-expressing cells, determined
Helios expression [22]. These conflicting data may reflect
limitations of each model. Thus, in vitro induced murine Tregs
do not have a stable iTreg phenotype and lose Foxp3 after TGF-
beta withdrawal, while human iTregs generated this way may be
unstable and/or poorly suppressive [24,30,31]. Also, given the
limited knowledge of the biological role of Helios in T cells, use of
immunodeficient mice could introduce additional confounding
variables. We therefore focused our studies primarily on Helios
expression in T cells present under natural conditions in untreated,
non-genetically altered, healthy young C57BL/6 mice, as well as
in 25–40 year old healthy human donors.
Over the last decade, numerous Treg subtypes were identified
[32]. Some of them, such as CD45RA+CD45RO-CD62L+
human Tregs, have a naı ¨ve phenotype comparable similar to
naı ¨ve conventional T cells, while others are more restricted to
Tregs. Such Treg selectivity may be based upon quantitative
differences such as high expression of CD25 and low expression of
CD127, or by the functional significance of the protein to Treg
biology. Examples of functionally significant Treg proteins include
CTLA-4 [9], CD39 [33], GARP [23,34], and CD120b (TNFR2)
[35], though these molecules are also expressed by other cells,
reducing their utility and typically requiring multiparameter
analysis. Thus, TNFR2 was shown to be up-regulated by Tregs
with the greatest suppression activity in both humans [35] and
mice [36], but also to be associated with increased resistance to
suppression when expressed by activated Teff cells [37]. In the
current work, Helios expression was not restricted to CD4+ cells,
and within the CD4+ fraction, Helios expression was not restricted
to Foxp3+ Tregs. However, we did find a common association
between high Helios expression and a set of Treg-known markers
including Foxp3, CD25, CD39, CTLA-4 and low levels of
CD127. As CD31 expression has become recognized as a marker
of recently emigrated, thymic-derived Tregs [15,38,39], we
expected that Helios+ CD4+ T cells (including Tregs) would co-
express CD31. However, we were surprised to find that CD31
expression was inversely associated with Helios expression in
Tregs. CD31 is cleaved from the surfaces of human T cells upon
TCR activation [14], so we also investigated the maturation
phenotype of Helios+ and Helios- cells using standard markers of
CD45 isoforms and CD62L expression. We found that Helios- T
cells (Tregs, CD4+Foxp3- cells, CD8 cells) in mice and humans
were enriched for naı ¨ve phenotypes, while Helios+ cells showed
more mature phenotypic characteristics. Since iTreg require
TCR-induced activation for their development, these data were
not consistent with the concept that naive nTregs are primarily
Helios+ and that iTregs are primarily Helios- cells.
Treg suppression assays provide the key activating and co-
stimulatory signals to analyze Treg functions under standardized
conditions. Using this in vitro system and analyzing the character-
istics of working Tregs and associated dividing responder cells, we
showed that Helios could be induced within responder cells (CD4
or CD8 Teffs) even without addition of TGF-beta or IL-2. Murine
CD4+ cells that upregulated Helios+ did not express Foxp3,
making unlikely the possibility that observed Helios expression
came from contaminant Tregs. In human Treg suppression assays,
Figure 7. Helios is not associated with Treg lineage commit-
ment in mice. (A) Murine CD4+ CD25- Teffs stimulated with CD3/CD28
mAbs, IL-2 and TGF-beta to become iTregs upregulated Helios in both
Foxp3+ and Foxp3- subsets (middle). Withdrawal of TCR stimulation
and TGF-beta led to loss of Helios expression (right). (B) Murine Tregs
after isolation (left) and after 4 d with IL-2 but without stimulation
(right). In resting conditions Helios expression decreased, and Foxp3
expression by Tregs decreased mainly in the Helios+ subset. (C)
Induction of Foxp3 in mouse CD8+ cells in the same conditions as in (A).
Foxp3+ converted CD8 cells co-expressed Helios and Ki-67.
doi:10.1371/journal.pone.0024226.g007
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PLoS ONE | www.plosone.org 8 August 2011 | Volume 6 | Issue 8 | e24226Figure 8. Helios+ expression correlates with Ki-67 expression in vivo. Murine thymic (left), lymph node (middle) and splenic (right) CD4+
gated cells were divided into Foxp3+ Tregs and Foxp3- cells (top row), and then divided into Helios+ and Helios- subsets (middle), and Ki-67
expression within each subset was analyzed (bottom).
doi:10.1371/journal.pone.0024226.g008
Figure 9. Helios expression in thymocytes depends on cell stimulation and not origin. (A) Helios- Foxp3+ subsets were gated within
murine thymic cells, and CD4 and CD8 distribution was analyzed. More than half (bottom) of Foxp3+ Helios- cells and 24% (top) of Foxp3
hi Helios-
cells in the thymus were immature CD4+ CD8+ DP thymocytes. (B) Murine thymic cells were incubated for 3 days with IL-2 only (non-stimulated, left
column) or were stimulated with CD3/CD28 mAbs and IL-2 (stimulated, right column). Ki-67 expression (top) and Helios expression (middle) in non-
stimulated cells decreased markedly; and Helios expression in thymic Tregs (CD4+ SP Foxp3+ cells) decreased from 91% to 57% (bottom).
doi:10.1371/journal.pone.0024226.g009
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expression exceeded Foxp3 expression significantly. Moreover,
human CD8 effector cells also upregulated Helios expression
under the same conditions. Helios was induced most prominently
among highly dividing cells, which are most activated and resistant
to Treg suppression. These data further substantiated our
hypothesis that Helios expression simply reflected T cell activation
and proliferation.
While examining Helios expression within Tregs present in
suppression assays, we noticed that Helios most prominently
expressed by dividing Tregs, analogous to the pattern seen in Teff
cells. Conversely, non-dividing Tregs rapidly lost Foxp3 and Helios
expression. This observation is consistent with the impaired
suppressive activity of human Treg seen after Helios knockdown
[40], though the phenotype and proliferation rate of Helios
knockdown Tregs, compared to unmanipulated or control siRNA
Tregs, were not described. On the other hand, Thornton et al [21]
n o t e dt h a te xv i v oe x p a n d e dh u ma nT r e g st r e a t e dw it hH e li o ssi R N A
had normal suppressive function. However, their experimental setup
was based on use of cells expanded for 14 days with high levels of
stimulation plus IL-2 supplementation. While the exact role of Helios
in T cells remains elusive, yet another member of the Ikaros family,
Eos, was shown to mediate Foxp3-dependent gene silencing and was
critical for Treg suppressive function [41].
To assess if Helios upregulation in vitro was further enhanced by
IL-2, and to analyze GARP expression, we stimulated murine
lymph node and spleen cells, and human PBMC, with CD3e/
CD28 mAbs6IL-2. Helios upregulation was increased by CD3/
CD28 stimulation as soon as 24 hours, with a moderate increase
upon addition of IL-2, while Foxp3 expression remained
unchanged. Helios expression did not correlate with GARP
expression in CD4+ T cells or Tregs, suggesting Helios expression
might be an activation marker and, indeed, Helios+ cells co-
expressed the Ki-67 proliferation marker. In addition, since the
short time incubation precluded division of thymic Helios+ Tregs
cells, these data indicated that Helios upregulation occurred in
previously Helios- cells. We also tested the effects of TGF-beta to
promote iTreg development and found Helios was upregulated in
both Foxp3+ and Foxp3- subsets. Withdrawal of stimulation led to
a rapid decline of Helios in Foxp3+ Helios+ and Foxp3- Helios+
subsets, while Foxp3 expression was maintained in the Helios-
iTregs subset. The fast down-regulation of Helios upon removing
TCR stimulation, or the absence of stimulatory signals, might
explain the effect observed by Thornton et al. whereby in vitro
induced iTregs remained Helios- [21]. Furthermore, the persis-
tence of remaining APC co-stimulation might explain Helios+
Foxp3+ co-expression, as observed by Verhagen and Wraith [22].
We next sought in vivo evidence of Helios expression. Analysis of
murine lymphoid tissues showed a close association of Helios and
Ki-67 expression. Our data help explain the marked Helios
expression of Tregs, since thymic CD4+ and CD8+ T cells have
higher Ki-67 expression than their peripheral counterparts.
Thornton et al. [21] also showed an absence of Helios- Foxp3+
in newborn mice until 7 days of life, and Foxp3+ Helios+ cells
expressed a high level of CD44 while Foxp3+ Helios- cells
appeared later and remained mostly CD44
low naı ¨ve for the first
weeks. These observations are in line with our hypothesis.
Neonatal murine T cells undergo rapid division just after leaving
the thymus, in a process termed homeostatic proliferation [42].
Short-term labeling revealed at least 10-fold more murine
neonatal cells of both the CD4+ and CD8+ populations within
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Neonatal dividing T cells (as well as Tregs) acquired a CD44+
phenotype, and, we would predict, would become Helios+ as a
result of their high proliferation rate. Later, as physiological
lymphopenia disappears and homeostatic proliferation declines,
the proportion of non-dividing T cells increases, and resting, non-
dividing Foxp3+Helios- with naı ¨ve CD44
low would appear in the
periphery. However, thymic cells have a high division rate
throughout life, explaining their relatively higher Helios expression
in comparison to peripheral cells. Consistent with this concept, we
found that in resting conditions thymocytes (including Tregs) lost
Helios expression, but that the same cells upregulated Helios,
exceeding in vivo physiologic level, under strong CD3/CD28
stimulation.
Thornton et al [21] and Fujimoto et al [44] suggested that the
small subset of Foxp3+ Helios- cells observed in the thymus
comprise iTregs that re-entered the thymus from the periphery.
However, we showed that more than half of these cells are
immature CD4+ CD8+ double-positive thymocytes. Fujimoto at
al. [44] also showed that excessive IL-6 production in IL-6
transgenic mice led to aberrant peripheral T cell activation and
increased Helios expression within Foxp3+ Tregs, but normal in
vitro and in vivo induction of iTregs from naı ¨ve IL-6 transgenic
CD4+ T cells, and no differences in iTreg induction after anti-IL-
6R mAb treatment. If Helios- Foxp3+ Tregs were iTregs whose
formation were inhibited by increased IL-6, then normal in vitro
and in vivo induction of iTregs from the same naı ¨ve IL-6 transgenic
CD4+ T cells contradict these in vivo observations. This
contradiction is resolved if Helios expression is considered as a
consequence of the cellular activation shown in these mice.
Therefore, the activated phenotype of T cells observed in IL-6
transgenic mice along with increased Helios expression supports
the cellular activation, but not the thymic-derived, hypothesis.
We could not find a relationship between age and Helios
expression in Tregs samples isolated from children, adults aged 25-
40 yrs or elderly persons, which supports the theory that Helios
expression may not be related to thymic involution in humans and
therefore may not be connected with the thymic origin of Tregs.
By serial analysis of Tregs obtained from liver transplant patients,
we showed that Helios expression was neither related to Foxp3
methylation nor to Treg suppressive function, though the latter
two factors are correlated with each other. Our data also do not
contradict recent findings by McClymont et al [45] showing
increased frequency of Helios- Foxp3+ IFN-gamma+ Tregs in
diabetic patients and increased Foxp3 methylation in Helios- IFN-
gamma+ Tregs from healthy donors, since they did not use nTregs
in any experiments, but rather, analyzed cells obtained from one
particular CD4+ CD127lo/- CD25+ CD45RA+ subset of natural
Tregs and then expanded for 2 wks under conditions of high
activation and IL-2 supplementation. Finally, we showed that
epigenetic changes in Tregs induced by exposure to HDACi and
DNMTi correlated with enhanced suppressive abilities, but were
not associated with any changes in Helios expression.
In conclusion, Helios can be induced within CD4+ T cells,
CD8+ T cells and in Tregs in response to cellular activation, and
regresses in the same cells under resting conditions. Based on our
Figure 10. Helios expression by human Tregs did not correlate with CD31 or suppressive function. (A) Two liver transplant patients
underwent serial analysis of Treg suppressive function, Foxp3 methylation and cell phenotype. At 3 mths post-transplant, Tregs had increased thymic
output of CD31+ Tregs and reduction of Helios+ Tregs; Helios was not co-expressed with CD31. (B) Tregs, CD4+CD25- Teffs and CD4-depleted APC
from healthy donor were used in suppression assays, with or without treatment with a DNMTi (Decitabine) or HDACi (SAHA). Enhancement of Treg
suppression by either agent (left) was not accompanied by change in Helios expression (right).
doi:10.1371/journal.pone.0024226.g010
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from induced Treg cells.
Materials and Methods
Ethics statement
Clinical studies were approved by the Institutional Review
Board of the Hospital of the University of Pennsylvania
(#810878), and animal studies were approved by the Institutional
Animal Care and Use Committee of The Children’s Hospital of
Philadelphia (approval number #2010-6-561).
DNMTi (DNA Methyl Transferase inhibitor) and HDACi
(Histone deacetylase inhibitor)
We purchased decitabine (5-Aza-29-deoxycytidine, DNMTi)
from Sigma and SAHA (Suberoylanilide hydroxamic acid, pan-
HDACi) from Cayman Chemical.
Human mononuclear cell isolation, Treg expansion and
Treg suppression assays
Mononuclear cell-enriched apheresis product was obtained by
leukapheresis of healthy volunteer donors (n=4; 2 females) by the
University of Pennsylvania Human Immunology Core. Specimens
were collected according to the protocol approved by the Hospital
of the University of Pennsylvania Institutional Review Board, and
informed consent was obtained from each donor. Human Treg
expansion was performed as described [46]; briefly, male donor
FACS-sorted CD25hi Tregs were incubated with OKT-3 CD3e
mAb-loaded artificial APC (K64.86) for 12–14 days in the
presence of IL-2 and human AB serum. Human Treg suppression
assays were performed, and Treg suppressive function calculated
as area under the standardized suppression curve (AUC), as
described [25]. Briefly, CD4+ CD25+ Tregs isolated by magnetic
beads (Miltenyi Biotec) were stimulated with CD3e mAb-coated
microbeads and incubated with CFSE-labeled PBMC at 1:1 to
1:16 Treg: PBMC ratios for 4 days. Experiments with Decitabine
(125 nM) and SAHA (200 nM) were performed with Tregs, CD4-
depleted APC and CD4+ CD25- Teffs, as described [25].
Human Foxp3 methylation assay
We isolated genomic DNA from CD4+ CD25+ beads-isolated
Tregs using Puregene Kit A (Qiagen), according to the
manufacturer’s instructions. To detect differentially methylated
DNA fractions, we exposed the DNA to two restriction enzymes,
one methylation-sensitive and the other methylation dependent.
We then performed enzymatic digestions according to the
manufacturer’s instructions (Methyl-Profiler DNA Methylation
Enzyme Kit, SABiosciences). Next, we conducted DNA methyl-
ation PCR arrays using custom Foxp3 primers (SABiosciences)
corresponding to the Treg-specific demethylated region (TSDR) of
human Foxp3. Using internal control digests, we calculated the
percent of methylated CpG islands in TSDR region of Foxp3 [24].
We defined 0–5% of methylation as "unmethylated Foxp3".
Murine mononuclear cell isolation and Treg and
thymocyte studies
We housed C57BL/6 mice (The Jackson Laboratory, Bar
Harbor, ME) in specific pathogen-free conditions and studied
them using a protocol approved by the Institutional Animal Care
and Use Committee of the Children’s Hospital of Philadelphia.
Spleen and lymph nodes were harvested, single cell suspensions
prepared and magnetic beads (Miltenyi Biotec) used to isolate
Treg cells (CD4+ CD25+), Teff cells (CD4+ CD25-), CD8+ T cells
and APC (Thy1.2-). Generation of iTreg cells was performed as
described [47]. Briefly, Teff cells were stimulated for 4 days with
CD3e/CD28 mAbs, in the presence of TGF-beta (3 ng/mL) and
IL-2 (25 U/mL); we used the same conditions for generation of
CD4+ and CD8+ iTreg cells. Murine Treg assays were performed
as described [48]. Briefly, Teff cells were labeled with CFSE and
stimulated for 72 h in the presence of irradiated APC (1:1) plus
CD3e mAb (1 mg/mL), with or without Treg added at 1:1-1:8
(Treg: Teff) ratios. In some experiments, we used CellTrace
(Invitrogen) to label Treg prior to these assays, so as to monitor
Treg proliferation independently of dividing CFSE-labeled Teff
cells. For thymocyte studies, thymi were harvested, single cell
suspensions prepared, and cells were stimulated for 3 days with IL-
2 (25 U/ml) with or without addition of CD3e/CD28 mAbs.
Flow Cytometry
We initially used anti-Helios mAbs generously gifted by Drs.
Angela M. Thornton and Ethan M. Shevach of the National
Institutes of Health, and later used the same Pacific Blue- and PE-
labeled hamster anti-mouse/human Helios mAbs once they
became commercially available (Biolegend). We purchased mAbs
to human CD4 (APC), CD8 (FITC), CD25 (PE and APC), CTLA-
4 (Pe-Cy5, PE) and Ki-67 (PerCP-Cy5.5) from BD Biosciences;
CD4 (Pacific blue, PE, FITC, APC-eFluor 780), CD25 (APC-
eFluor 780, Pe-Cy5, Pe-Cy7), CD39 (Pe-Cy7), CD45RA (PE-
Cy7), CD45RO (PE), CD62L (Pe-Cy5, APC-eFluor 780), CD127
(FITC, PE, Alexa Fluor 647) and FOXP3 (PE, Alexa Fluor 647,
Pacific blue and FITC, clones PCH101 and 236A/E7) from
eBioscience; CD4 (PE-Texas Red) from Invitrogen; CD8 (PerCP/
Cy5.5), CD31 (Pe-Cy7) and CD45RA (Pacific blue), from
Biolegend; TNFRII/TNFRSF1B (CD120b, PE) from R&D and
GARP (unconjugated and ATTO 488, Plato-1 clone) from Alexis
Biochemicals. We purchased mAbs to murine CD4 (APC-eFluor
780, Pe-Cy5, Pacific blue, PE), CD8 (Pe-Cy7, PE, eFluor 605NC),
CD25 (PE, PE-Cy5, PE-Cy7, APC-eFluor 780), CD44 (FITC),
CD44RB (FITC), CD62L (APC-eFluor 780), Foxp3 (FJK-16a
clone, Pe-Cy5, APC) and GARP (PE) from eBioscience. For all
experiments, intranuclear staining for Foxp3 and Helios, and
intracellular staining for CTLA-4 and Ki-67, were performed after
surface staining; permeabilization was performed using the Foxp3
Fix/Perm Buffer kit (eBioscience). Cell fluorescence was measured
using a Cyan flow cytometer (Dako) and data analyzed using
Flowjo software (TreeStar). Most flow cytometry assays were
performed with additional staining with LIVE/DEAD Fixable
Aqua Dead Cell Stain Kit (Invitrogen) to improve the quality of
gating live cells and decrease non-specific staining of dead cells.
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